Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation. [electronic resource]
Producer: 20161227Description: 68-74 p. digitalISSN:- 1879-0593
- Aged
- Antineoplastic Agents -- therapeutic use
- Cetuximab -- therapeutic use
- Combined Modality Therapy -- methods
- Deglutition Disorders -- epidemiology
- Female
- Humans
- Male
- Middle Aged
- Oropharyngeal Neoplasms -- drug therapy
- Papillomaviridae
- Papillomavirus Infections -- complications
- Quality of Life
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.